Author

Juan Pablo Vega

Every paper listing this name carries an ORCID.

Identified by ORCID

Juan Pablo VegaiD1 paper · Fundación Ciencia and Vida

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Álvaro LladseriD· 1 shared Andrés Hernández‐OliverasiD· 1 shared Diego A. FigueroaiD· 1 shared Fabiola OsorioiD· 1 shared Felipe Ardiles· 1 shared Felipe Flores· 1 shared Felipe Gálvez‐CancinoiD· 1 shared Hugo GonzáleziD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Álvaro LladserORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintMay 16, 2024

Long-term efficacy of adoptive cell therapy is determined by host CD8+ T cells and undermined by lymphodepleting preconditioning

Diego A. Figueroa, Juan Pablo Vega, Andrés Hernández‐Oliveras…·Álvaro Lladser

This study shows that host CD8+ T cells enhance adoptive cell therapy (ACT) efficacy against melanoma, while lymphodepleting preconditioning reduces long-term effectiveness by impairing host immunity.

DOI 10.1101/2024.05.16.594554

𝕏 PostBluesky